ClinicalTrialExchange
  • Home
  • For Patients
  • For Professionals
  • About
  • Contact

Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for HIV Wasting Syndrome

  • Evaluate Weight Gain Using 2 Different Formulations of Megestrol Acetate Oral Suspension for AIDS-related Weight Loss
  • Growth Hormone in the Treatment of HIV-Associated Wasting
  • Nutrition Intervention in AIDS Wasting
  • AIDS Wasting in Women: Anabolic Effects of Testosterone
  • Randomized Placebo-Controlled Study of Aerobic Exercise and Resistance Training Plus Megestrol Acetate for HIV-Wasting
  • Compassionate Use Study of Two Dose Levels of Thalidomide in Adults With HIV Wasting Syndrome
  • A Phase II, Parallel Group, Randomized, Placebo-Controlled Study of the Safety and Efficacy of Thalidomide in Reducing Weight Loss in Adults With HIV Wasting Syndrome
  • A Study of Megestrol Acetate Alone or in Combination With Testosterone Enanthate Drug in the Treatment of HIV-Associated Weight Loss
  • A Study to Evaluate High Protein Supplementation in HIV-Positive Patients With Stable Weight Loss
  • A Study to Evaluate the Effect of Nandrolone Decanoate in Women With HIV-Associated Weight Loss
  • A Phase I/II Study to Evaluate Single Agent and Combination Therapy With Megestrol Acetate and Dronabinol for the Treatment of HIV-Wasting Syndrome
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies

Clinical Trials data from clinicaltrials.gov

Powered by DrugPatentWatch.

  • About
  • Contact
  • Follow ClinicalTrialsExchange:

      ClinicalTrialsExchange Linkedin Group